The global home infusion therapy devices market is on the brink of remarkable expansion, projected to grow from USD 2.3 billion in 2023 to an estimated USD 4.4 billion by 2033, representing a compound ...
As hospitals around the U.S. report IV fluid shortages, Baxter has increased supply allocations for direct customers and distributors. It plans to return to 90% to 100% allocation of certain ...
The impact of the Baxter plant closure led CVS to close its Coram infusion pharmacy division and instruct parenteral patients to seek new providers. The disruption left approximately 25,000 patients ...
Ad in partnership with CVS The busy holiday season is upon us and there’s a good chance your short on time and expendable cash. Unfortunately, just because your social and work calendar are filling up ...